| Dr Michael Richard Gallagher, MD | |
|
1010 E 3rd St, Suite 202, Chattanooga, TN 37403-2109 | |
| (423) 265-2233 | |
| (423) 756-8265 |
| Full Name | Dr Michael Richard Gallagher |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 37 Years |
| Location | 1010 E 3rd St, Chattanooga, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427147214 | NPI | - | NPPES |
| 140003990 | Other | TN | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | MD26400 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Erlanger Medical Center | Chattanooga, TN | Hospital |
| Murphy Medical Center Inc | Murphy, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Chattanooga Hamilton County Hospital Authority | 0547179731 | 156 |
| Erlanger Health | 1153780226 | 352 |
News Archive
Rebiotix Inc. today announced that U.S. Food and Drug Administration has designated its lead Microbiota Restoration Therapy (MRT) RBX2660 as a Breakthrough Therapy for the treatment of recurrent Clostridium difficile (C diff) infection, a challenging to treat gastrointestinal (GI) infection that causes 29,000 deaths in the U.S. annually.
In Texas, lawmakers cut short debate and approved new abortion regulations that would ban most abortions after 20 weeks of pregnancy, among other things. In Wisconsin, a bill would require an abortion doctor to make burial arrangements for a fetus.
Yale University scientists have developed a novel chemical process that may lead to the creation of a new class of antibiotics.
Dramatic reductions in hospitalization for heart attacks and in the need for revascularization surgery were achieved in angina patients treated with the selective heart rate reduction medication ivabradine on top of current standard treatment, according to results of a major clinical study presented today at the 2009 Canadian Cardiovascular Congress in Edmonton.
› Verified 2 days ago
| Entity Name | Chattanooga Hamilton County Hospital Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154751931 PECOS PAC ID: 0547179731 Enrollment ID: O20040302001086 |
News Archive
Rebiotix Inc. today announced that U.S. Food and Drug Administration has designated its lead Microbiota Restoration Therapy (MRT) RBX2660 as a Breakthrough Therapy for the treatment of recurrent Clostridium difficile (C diff) infection, a challenging to treat gastrointestinal (GI) infection that causes 29,000 deaths in the U.S. annually.
In Texas, lawmakers cut short debate and approved new abortion regulations that would ban most abortions after 20 weeks of pregnancy, among other things. In Wisconsin, a bill would require an abortion doctor to make burial arrangements for a fetus.
Yale University scientists have developed a novel chemical process that may lead to the creation of a new class of antibiotics.
Dramatic reductions in hospitalization for heart attacks and in the need for revascularization surgery were achieved in angina patients treated with the selective heart rate reduction medication ivabradine on top of current standard treatment, according to results of a major clinical study presented today at the 2009 Canadian Cardiovascular Congress in Edmonton.
› Verified 2 days ago
| Entity Name | Erlanger Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477256303 PECOS PAC ID: 1153780226 Enrollment ID: O20230707000849 |
News Archive
Rebiotix Inc. today announced that U.S. Food and Drug Administration has designated its lead Microbiota Restoration Therapy (MRT) RBX2660 as a Breakthrough Therapy for the treatment of recurrent Clostridium difficile (C diff) infection, a challenging to treat gastrointestinal (GI) infection that causes 29,000 deaths in the U.S. annually.
In Texas, lawmakers cut short debate and approved new abortion regulations that would ban most abortions after 20 weeks of pregnancy, among other things. In Wisconsin, a bill would require an abortion doctor to make burial arrangements for a fetus.
Yale University scientists have developed a novel chemical process that may lead to the creation of a new class of antibiotics.
Dramatic reductions in hospitalization for heart attacks and in the need for revascularization surgery were achieved in angina patients treated with the selective heart rate reduction medication ivabradine on top of current standard treatment, according to results of a major clinical study presented today at the 2009 Canadian Cardiovascular Congress in Edmonton.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael Richard Gallagher, MD 1010 E 3rd St, Suite 202, Chattanooga, TN 37403-2109 Ph: (423) 265-2233 | Dr Michael Richard Gallagher, MD 1010 E 3rd St, Suite 202, Chattanooga, TN 37403-2109 Ph: (423) 265-2233 |
News Archive
Rebiotix Inc. today announced that U.S. Food and Drug Administration has designated its lead Microbiota Restoration Therapy (MRT) RBX2660 as a Breakthrough Therapy for the treatment of recurrent Clostridium difficile (C diff) infection, a challenging to treat gastrointestinal (GI) infection that causes 29,000 deaths in the U.S. annually.
In Texas, lawmakers cut short debate and approved new abortion regulations that would ban most abortions after 20 weeks of pregnancy, among other things. In Wisconsin, a bill would require an abortion doctor to make burial arrangements for a fetus.
Yale University scientists have developed a novel chemical process that may lead to the creation of a new class of antibiotics.
Dramatic reductions in hospitalization for heart attacks and in the need for revascularization surgery were achieved in angina patients treated with the selective heart rate reduction medication ivabradine on top of current standard treatment, according to results of a major clinical study presented today at the 2009 Canadian Cardiovascular Congress in Edmonton.
› Verified 2 days ago
Joseph Hardy Miller, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1010 E 3rd St, Suite 202, Chattanooga, TN 37403 Phone: 423-265-2233 Fax: 423-756-8265 | |
Ranjith Babu, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 725 Glenwood Dr Ste E790, Chattanooga, TN 37404 Phone: 423-206-4140 | |
Dr. Timothy Alexander Strait, M.D. Neurological Surgery Medicare: Medicare Enrolled Practice Location: 1010 E 3rd St, Suite 202, Chattanooga, TN 37403 Phone: 423-265-2233 Fax: 423-756-8265 | |
Dr. Mayshan Ghiassi, Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 725 Glenwood Dr Ste E486, Chattanooga, TN 37404 Phone: 423-206-9480 Fax: 423-206-9481 | |
Dr. Peter Eric Boehm Jr., MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1010 E 3rd St Ste 202, Chattanooga, TN 37403 Phone: 423-265-2233 Fax: 423-756-8265 | |
Prayash Gaurang Patel, Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1010 E 3rd St, Suite 202, Chattanooga, TN 37403 Phone: 423-265-2233 Fax: 423-756-8265 |